{"nct_id":"NCT01142466","title":"A Phase IV Study of Rebif ® 44mcg Administered Three Times Per Week by Subcutaneous Injection Compared With no Treatment in the Therapy of Relapsing Multiple Sclerosis After Mitoxantrone","status":"COMPLETED","status_verified_date":"2014-01","start_date":"2005-12","start_date_type":null,"primary_completion_date":"2009-12","primary_completion_date_type":"ACTUAL","completion_date":"2010-01","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["MRK"]}